publication venue for
- Is Hughes-Stovin syndrome Behçet's disease? 2004
- Ichthyosiform and morpheaform sarcoidosis. 1990
- Sjögren's syndrome presenting with hypereosinophilia, lymphopenia and circulating immune complexes. 1984
- Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository. 2025
- A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale.. 39 Suppl 131. 2021
- Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares.. 39. 2021
- Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.. 35. 2017
- Practice patterns of ANCA-associated vasculitis: exploring differences among subspecialties at a single academic medical centre.. 32. 2014
- Perioperative outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a population-based study.. 31. 2013
- Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.. 32. 2013
- Implication of VEGFR2 in systemic lupus erythematosus: a combined genetic and structural biological approach.. 31. 2012
- Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis.. 27. 2009
- Disparities in joint replacement utilization: a quality of care issue.. 25. 2007
- Methods to develop arthritis and osteoporosis measures: a view from the National Committee for Quality Assurance (NCQA).. 25. 2007
- Skin manifestations in vasculitis and erythema nodosum.. 24. 2006
- Role of adalimumab in the treatment of early rheumatoid arthritis.. 21. 2003
- Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death.. 19. 2001
- A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis.. 18. 2000
- Alternative complement pathway in hypocomplementemic/normal C1s-C1 inhibitor complex patients with SLE.. 8. 1990
- Probing of the rheumatoid factor (RF) V gene repertoire in rheumatoid arthritis (RA) by hybridoma clones.. 8 Suppl 5. 1990
- Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin.. 6. 1988
- Immunologic safety of ibuprofen in rheumatoid arthritis: preliminary evidence.. 2. 1984
- Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years.. 20. 2002
- A case of VATER association mimicking spondylarthropathy.. 18. 2000
- Slow evolution to systemic lupus erythematosus of isolated autoimmune thrombocytopenia.. 18. 2000
- Granulomatous disease and the two faces of Janus: divergent effects of tofacitinib therapy for inflammatory arthritis. 2021
- CTLA-4 gene variants are not associated with Behçet's disease or its clinical manifestations. 2008
- Comment on "Quality indicators for psoriatic arthritis". 2008
- TNF polymorphisms in Lebanese patients with Behçet's disease. 2008
- The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis. 2005
- Behçet's disease: does lack of knowledge result in under-diagnosis? 2004
- Treatment of lupus pregnancy: can we reach consensus?. 10. 1992
- Achieving remission in clinical practice: lessons from clinical trial data. 2013
- Signal transduction in T lymphocytes. 1999
- Measuring methotrexate polyglutamates. 2010
- Response criteria for cutaneous SLE in clinical trials. 2007
- Early rheumatoid arthritis in African-Americans: the CLEAR Registry. 2003
- The role of Fc gamma receptors in mononuclear phagocyte system function. 1989